Pharmaceutical Perspectives of HECT-TYPE Ubiquitin Ligase Smurf1

E-ISSN： 1873-4286|19|18|3226-3233

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.18, 2013-06, pp. : 3226-3233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 157-174

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy

Current Cancer Drug Targets, Vol. 16, Iss. 2, 2016-02 ,pp. : 136-146

Bentham Science Publishers

Access to resources Recommend Favorite

Micellar Nanocarriers: Pharmaceutical Perspectives

By Torchilin V.

Pharmaceutical Research, Vol. 24, Iss. 1, 2007-01 ,pp. : 1-16

Springer Publishing Company

Access to resources Recommend Favorite

Ubiquitin ligases as therapeutic targets in HIV-1 infection

By Votteler Jörg Schubert Ulrich

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 131-143

Informa Healthcare

Access to resources Recommend Favorite

Current Pharmaceutical Design of Antituberculosis Drugs: Future Perspectives

Current Pharmaceutical Design, Vol. 16, Iss. 24, 2010-08 ,pp. : 2656-2665

Bentham Science Publishers

Access to resources Recommend Favorite